Table 1.

Clinicopathological features of the HNSCC patients in this study.

HN#	Gender	Age (at diagnosis)	Tumor site	T-stage	N-stage
HN15–8172	MALE	52	Oropharynx	T2	N2
HN15–8088	MALE	51	Oropharynx	T1	N2
HN14–7943	MALE	43	Larynx	T4	N2
HN14–7928	MALE	54	Larynx	T3	N0
HN14–7800	FEMALE	77	Oral cavity	T4	N0
HN15–8068	FEMALE	57	Oral cavity	T2	N2
HN14–7900	MALE	49	Oropharynx	TX	N2
HN14–7893	MALE	75	Oral cavity	T4	N0
HN14–7927	MALE	66	Larynx	TX	NX
HN15–8010	FEMALE	80	Oral cavity	T4	N0
HN15–8021	MALE	24	Oral cavity	T3	N0
HN15–8110	MALE	74	Oropharynx	T4	N2
HN15–8144	FEMALE	67	Oral cavity	T3	N0
HN15–8173	MALE	63	Larynx	T4	N0
HN15–8202	FEMALE	69	Oral cavity	T4	N2
HN15–8228	MALE	60	Oropharynx	T3	N2
HN15–8253	MALE	60	Oropharynx	T3	N2
HN15–8290	MALE	27	Oral cavity	T2	N2
HN15–8296	MALE	67	Larynx	T3	N2
HN15–8294	MALE	64	Oropharynx	T4	N2
HN15–8180	MALE	50	Oral cavity	T4	N1
HN14–7881	MALE	54	Oropharynx	T1	N2
HN14–7909	FEMALE	58	Oral cavity	T2	N1
HN14–7949	MALE	72	Larynx	T3	N2
HN14–7960	MALE	61	Larynx	T4	N2
HN14–7961	MALE	57	Oral cavity	T2	N0